Here are my suggestions for some of the top articles about asthma published recently:
Asthma and Allergen Sensitization start earlier in life than previolsy reported (age 2 for asthma, age 1 for allergy), dust mite is the culprit in 80% http://buff.ly/1uU6P5u
Exercise-induced bronchoconstriction (EIB) underdiagnosis may result in habitual avoidance of sports and physical activity, chronic deconditioning, weight gain, poor asthma control, low self-esteem, and reduced quality of life. Improving EIB diagnosis: no existing EIB screening questionnaire had adequate sensitivity and specificity http://buff.ly/1k1KEFT
Vitamin D supplementation in adults with asthma is not indicated - VIDA RCT http://buff.ly/1hZ1KzT
Humanized monoclonal antibody (AMG 157) against a novel target in human asthma, thymic stromal lymphopoietin (TSLP) http://buff.ly/1knrvON
Irritant-induced (occupational) asthma (IIA) - EAACI position paper http://buff.ly/1omacyu
Climate change and respiratory diseases http://buff.ly/1k8txiB (free full text)
Childhood asthma phenotypes in the twenty-first century http://buff.ly/1k8tHX5 (free full text)
The role of macrolides in asthma - The Lancet Respiratory Medicine http://buff.ly/1lRmbUC (free full text after registration)
Quilizumab: New Inhaled Drug Shows Promise Against Asthma, Allergies http://buff.ly/1mXuLSF
Thiazolidinediones may provide a new anti-inflammatory approach to asthma http://buff.ly/1r14W4x
Revisiting an Old Therapy: Theophylline in Asthma http://buff.ly/1r1aXhI
Omalizumab may have anti-inflammatory effects on small airways and reverse airway remodeling http://buff.ly/1r1bccG
Impact of azithromycin therapy on airway microbiota in asthma: decreased bacterial richness, Anaerococcus dominant http://buff.ly/1vOM5df
Survey of 8,000 asthma patients: poor control in 45%, yet most regarded their asthma as not serious and controlled http://buff.ly/1qLVDaX
EHR–Generated Interventions to Reduce Asthma Risk: Seeing the Glass Half Full http://buff.ly/1yrkphB
Children treated daily with ICS grow 0.5 cm less during the first year of treatment, no difference second year http://buff.ly/1jSwb1f
Nebulizers are everywhere, despite years of research showing that MDIs are equivalent with lower cost/side effects http://buff.ly/Uoefj6
In elderly asthmatics, vitamin D supplementation for 12 weeks improved ACT scores http://www.aacijournal.com/content/10/1/48
Severe asthma: “What to do when asthma is not doing well?” (click to enlarge the image).
The articles were selected from Twitter @Allergy and RSS subscriptions. Some of the top allergy accounts on Twitter contributed links. I appreciate the curation provided by @Aller_MD @IgECPD @DrAnneEllis @mrathkopf @MatthewBowdish.
Please feel free to send suggestions for articles to AllergyGoAway AT gmail DOT com and you will receive an acknowledgement in the next edition of this publication.
Asthma and Allergen Sensitization start earlier in life than previolsy reported (age 2 for asthma, age 1 for allergy), dust mite is the culprit in 80% http://buff.ly/1uU6P5u
Exercise-induced bronchoconstriction (EIB) underdiagnosis may result in habitual avoidance of sports and physical activity, chronic deconditioning, weight gain, poor asthma control, low self-esteem, and reduced quality of life. Improving EIB diagnosis: no existing EIB screening questionnaire had adequate sensitivity and specificity http://buff.ly/1k1KEFT
Vitamin D supplementation in adults with asthma is not indicated - VIDA RCT http://buff.ly/1hZ1KzT
Humanized monoclonal antibody (AMG 157) against a novel target in human asthma, thymic stromal lymphopoietin (TSLP) http://buff.ly/1knrvON
Irritant-induced (occupational) asthma (IIA) - EAACI position paper http://buff.ly/1omacyu
Climate change and respiratory diseases http://buff.ly/1k8txiB (free full text)
Childhood asthma phenotypes in the twenty-first century http://buff.ly/1k8tHX5 (free full text)
The role of macrolides in asthma - The Lancet Respiratory Medicine http://buff.ly/1lRmbUC (free full text after registration)
Quilizumab: New Inhaled Drug Shows Promise Against Asthma, Allergies http://buff.ly/1mXuLSF
Thiazolidinediones may provide a new anti-inflammatory approach to asthma http://buff.ly/1r14W4x
Revisiting an Old Therapy: Theophylline in Asthma http://buff.ly/1r1aXhI
Omalizumab may have anti-inflammatory effects on small airways and reverse airway remodeling http://buff.ly/1r1bccG
Impact of azithromycin therapy on airway microbiota in asthma: decreased bacterial richness, Anaerococcus dominant http://buff.ly/1vOM5df
Survey of 8,000 asthma patients: poor control in 45%, yet most regarded their asthma as not serious and controlled http://buff.ly/1qLVDaX
EHR–Generated Interventions to Reduce Asthma Risk: Seeing the Glass Half Full http://buff.ly/1yrkphB
Children treated daily with ICS grow 0.5 cm less during the first year of treatment, no difference second year http://buff.ly/1jSwb1f
Nebulizers are everywhere, despite years of research showing that MDIs are equivalent with lower cost/side effects http://buff.ly/Uoefj6
In elderly asthmatics, vitamin D supplementation for 12 weeks improved ACT scores http://www.aacijournal.com/content/10/1/48
Severe asthma: “What to do when asthma is not doing well?” (click to enlarge the image).
The articles were selected from Twitter @Allergy and RSS subscriptions. Some of the top allergy accounts on Twitter contributed links. I appreciate the curation provided by @Aller_MD @IgECPD @DrAnneEllis @mrathkopf @MatthewBowdish.
Please feel free to send suggestions for articles to AllergyGoAway AT gmail DOT com and you will receive an acknowledgement in the next edition of this publication.